Fundamental Analysis Discussion Only (IXC Thread), page-2

Just to add to the fundamentals based off the recent MST presentation

I think Tom said this well in terms of the NASA thing. Like why the f would they go after it when the market is tiny. If NASA on the other hand would fund the trial then why not.

The other thing he said well is that even though our TAM is 1 billion, its an encumbered market meaning there is NO OTHER companies out there targeting our market. Yes we could go for stroke or other diseases which have much larger TAMs however there is like 40 other companies going for the same thing. Risk in IIH is low IMO no competitors decent size TAM that is growing on a year on year basis. Time is the only thing holding us back with lack of interest but every day the closer we get to our goal the greater our valuation increases.